Therapeutic Goods Regulations (Amendment)

Overview

The Therapeutic Goods Regulations (Amendment) 1987, issued under the authority of the Minister for Community Services and Health, was enacted to address the need for a more structured and expert approach to the evaluation of therapeutic devices and goods in Australia. This amendment introduced the Therapeutic Device Evaluation Committee (TDEC) to provide the Minister with scientific and medical expertise in assessing therapeutic devices and other therapeutic goods. TDEC’s role includes making medical and scientific evaluations of referred and self-referred therapeutic devices and goods, and providing necessary advice on their importation, production, and distribution within Australia. This initiative aims to enhance the efficiency and effectiveness of the evaluation process, recognising the growing complexity of therapeutic goods. Additionally, the Australian Drug Evaluation Committee’s functions were expanded to cover therapeutic devices, ensuring a comprehensive approach to the evaluation of therapeutic goods with both chemical and non-chemical features. The Regulations also include minor amendments and the repeal of a regulation pertaining to the remuneration of committee members, which is now governed by the Remuneration Tribunal.

Scope and Application

The Therapeutic Goods Regulations (Amendment) issued under the Therapeutic Goods Act 1966 establish a new committee known as the Therapeutic Device Evaluation Committee (TDEC) to provide expert medical and scientific evaluations of therapeutic devices and certain therapeutic goods. The Act applies to the TDEC, which comprises a minimum of six and a maximum of eight members appointed by the Minister for Community Services and Health, each an expert in relevant fields such as anaesthetics, bioengineering, and medicine. TDEC’s primary role is to evaluate therapeutic devices and other therapeutic goods referred by the Minister, offering advice on their importation, production, and distribution within Australia. The Regulations extend the functions of the Australian Drug Evaluation Committee to include therapeutic devices, enhancing the efficiency of evaluations for goods with both chemical and non-chemical features. The scope of the Act is national, covering all therapeutic goods within Australia, with no specific geographic exclusions noted. The establishment of TDEC aims to streamline and improve the evaluation processes for therapeutic devices and certain therapeutic goods, ensuring they meet necessary medical and scientific standards.

Key Provisions

The Therapeutic Goods Act 1966 (the Act) has been amended by the Therapeutic Goods Regulations (Amendment) to establish the Therapeutic Device Evaluation Committee (TDEC) (subparagraph 30(a)(i)). This new committee is established to evaluate therapeutic devices and other goods for therapeutic use that are not classified as therapeutic devices, with a focus on both chemical and non-chemical features. The specific functions of TDEC, as outlined in the Regulations, include making medical and scientific evaluations of therapeutic devices and other goods for therapeutic use as referred by the Minister or at the Committee's discretion (subparagraph 30(a)(i)). TDEC is also tasked with providing advice to the Minister on the importation, production, and distribution of these evaluated goods within Australia, and this advice may be directed to other persons or bodies as the Minister sees fit. The Act imposes several obligations on TDEC, primarily centred around the evaluation and advice functions. TDEC must conduct thorough medical and scientific evaluations of therapeutic devices and other goods for therapeutic use, ensuring that these evaluations are based on scientific and medical expertise (subparagraph 30(a)(i)). Additionally, TDEC is responsible for furnishing the Minister with necessary advice concerning the importation, production, and distribution of evaluated therapeutic goods within Australia. This advice must be detailed and based on the Committee's evaluations, and it may be relayed to other entities as directed by the Minister. Breaches of the obligations and requirements set out in the Act may lead to various consequences. While the specific offences and penalties are not detailed in the Regulations, the Act generally provides for both civil and criminal penalties for non-compliance. The precise nature and severity of these penalties would depend on the specific breach and the provisions of the Act that are contravened. Generally, civil penalties may include fines, while criminal penalties could involve imprisonment, reflecting the seriousness of the non-compliance with the Act’s provisions. The Regulations ensure that the establishment of TDEC and its functions are clearly defined, thereby facilitating a more efficient and comprehensive evaluation process for therapeutic goods.